Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Hodgkin Disease 1Cardiovascular Diseases 1

Interventions

Cyclophosphamide 17fludarabine phosphate 12pembrolizumab 11Brentuximab Vedotin 11Nivolumab 10Mycophenolic Acid 10fludarabine 9Doxorubicin 9Dacarbazine 9Whole-Body Irradiation 8Vinblastine 7Magnetic Resonance Spectroscopy 7Filgrastim 7Etoposide 7Cyclosporine 7Specimen Handling 6Sirolimus 5Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Busulfan 5Tacrolimus 4Gemcitabine 4pegfilgrastim 3Vinorelbine 3Radiation 3Cyclosporins 3Carmustine 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Physical Conditioning, Human × 90 days × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡